Patent ID: 7659242
Filing Date: 2010-02-09
Classification: A23K,A23L,A23V,A61K,A61P

Abstract:
1. A method of treatment of insulin resistance, obesity, diabetes, fatty liver, hypercholesterolemia, dyslipidemia, atherosclerosis, coronary heart disease, thrombosis, stenosis, secondary stenosis, myocardial infarction, stroke, elevated blood pressure, endothelial dysfunction, procoagulant state, polycystic ovary syndrome, the metabolic syndrome, reducing the growth of cancer cells and/or inhibiting the metastasis of metastatic neoplasms, an inflammatory disorder, and a proliferate skin disorder comprising the administration of a pharmaceutical or nutritional composition comprising a combination of: 1) a protein material; and 2) one or more compounds comprising non β-oxidizable fatty acid entities represented by (a) the general formula R″—COO—(CH (b) the general formula (I),  wherein R1, R2, and R3 represent wherein R1, R2, and R3 are chosen independently from i), ii), iii), or iv), but at least one of R1, R2, or R3 is defined by iii); and/or (c) the general formula (II),  wherein A1, A2 and A3 are chosen independently and represent an oxygen atom, a sulphur atom or an N—R4 group in which R4 is a hydrogen atom or a linear or branched alkyl group, saturated or unsaturated, optionally substituted, containing from 1 to 5 carbon atoms; wherein R1, R2, and R3 represent wherein R1, R2, and R3 are chosen independently from i), ii), iii), or iv), but at least one of R1, R2, or R3 is defined by iii); and/or a salt, prodrug or complex of the compounds according to (a)-(c).